Quest Diagnostics CEO Stephen Rusckowski's 2019 pay rises 2% to $10.1M
Quest Diagnostics reports 2019 executive compensation
By ExecPay News
Published: April 8, 2020
Quest Diagnostics reported fiscal year 2019 executive compensation information on April 8, 2020.
In 2019, five executives at Quest Diagnostics received on average a compensation package of $4.8M, a 11% increase compared to previous year.
Stephen H. Rusckowski, Chief Executive Officer, received $10.1M in total, which increased by 2% compared to 2018. 42.97% of Rusckowski's compensation, or $4.3M, was in stock awards. Rusckowski also received $1.4M in non-equity incentive plan, $3M in option awards, $1.1M in salary, as well as $256.7K in other compensation.
Manuel O. Mendez, Senior Vice President and Chief Commercial Officer, received a compensation package of $4.6M. 63.03% of the compensation package, or $2.9M, was in stock awards.
Mark J. Guinan, Chief Financial Officer, earned $3.3M in 2019, a 3% increase compared to previous year.
James E. Davis, Executive Vice President, General Diagnostics, received $3.1M in 2019, which increases by 2% compared to 2018.
Carrie Eglinton Manner, Senior Vice President, Advanced Diagnostics, earned $2.7M in 2019, a 7% decrease compared to previous year.
Chief Executive Officer
Chief Financial Officer
Senior Vice President and Chief Commercial Officer
Executive Vice President, General Diagnostics